{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:21:48Z","timestamp":1787167308854,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T00:00:00Z","timestamp":1362873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T00:00:00Z","timestamp":1362873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s15010-013-0439-6","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T04:58:07Z","timestamp":1362805087000},"page":"791-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989\u20132010)"],"prefix":"10.1007","volume":"41","author":[{"given":"S.","family":"Ben-Shimol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Schonmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Givon-Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ephros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,10]]},"reference":[{"key":"439_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344:1378\u201388.","journal-title":"N Engl J Med"},{"key":"439_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1542\/peds.2005-1314","volume":"116","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2005","unstructured":"American Academy of Pediatrics Committee on Infectious Diseases. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics. 2005;116:496\u2013505.","journal-title":"Pediatrics"},{"key":"439_CR3","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1016\/j.vaccine.2006.03.034","volume":"24","author":"MP Girard","year":"2006","unstructured":"Girard MP, Preziosi MP, Aguado MT, Kieny MP. A review of vaccine research and development: meningococcal disease. Vaccine. 2006;24:4692\u2013700.","journal-title":"Vaccine"},{"key":"439_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","volume":"19","author":"LH Harrison","year":"2006","unstructured":"Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev. 2006;19:142\u201364.","journal-title":"Clin Microbiol Rev"},{"key":"439_CR5","doi-asserted-by":"publisher","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","volume":"27","author":"LH Harrison","year":"2009","unstructured":"Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27:B51\u201363.","journal-title":"Vaccine"},{"key":"439_CR6","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"DS Stephens","year":"2007","unstructured":"Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196\u2013210.","journal-title":"Lancet"},{"key":"439_CR7","first-page":"1","volume":"15","author":"A Vyse","year":"2011","unstructured":"Vyse A, Wolter JM, Chen J, Ng T, Soriano-Gabarro M. Meningococcal disease in Asia: an under-recognized public health burden. Epidemiol Infect. 2011;15:1\u201319.","journal-title":"Epidemiol Infect"},{"key":"439_CR8","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(00)03502-9","volume":"356","author":"MK Taha","year":"2000","unstructured":"Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356:2159.","journal-title":"Lancet"},{"key":"439_CR9","doi-asserted-by":"publisher","first-page":"B30","DOI":"10.1016\/j.vaccine.2009.05.003","volume":"27","author":"D Pace","year":"2009","unstructured":"Pace D, Pollard AJ, Messonier NE. Quadrivalent meningococcal conjugate vaccines. Vaccine. 2009;27:B30\u201341.","journal-title":"Vaccine"},{"key":"439_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","volume":"5","author":"MD Snape","year":"2005","unstructured":"Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis. 2005;5:21\u201330.","journal-title":"Lancet Infect Dis"},{"key":"439_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4161\/hv.19619","volume":"8","author":"CE Frasch","year":"2012","unstructured":"Frasch CE, Preziosi MP, LaForce FM. Development of a group A meningococcal conjugate vaccine, MenAfriVac\u2122. Hum Vaccin Immunother. 2012;8:715\u201324.","journal-title":"Hum Vaccin Immunother"},{"key":"439_CR12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","volume":"51","author":"P Balmer","year":"2002","unstructured":"Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol. 2002;51:717\u201322.","journal-title":"J Med Microbiol"},{"key":"439_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","volume":"10","author":"M Sadarangani","year":"2010","unstructured":"Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines\u2014an unfinished story. Lancet Infect Dis. 2010;10:112\u201324.","journal-title":"Lancet Infect Dis"},{"key":"439_CR14","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","volume":"29","author":"PB Keiser","year":"2011","unstructured":"Keiser PB, Biggs-Cicatelli S, Moran EE, et al. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine. 2011;29:1413\u201320.","journal-title":"Vaccine"},{"key":"439_CR15","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1016\/j.vaccine.2010.08.048","volume":"28","author":"PB Keiser","year":"2010","unstructured":"Keiser PB, Gibbs BT, Coster TS, et al. A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA. Vaccine. 2010;28:6970\u20136.","journal-title":"Vaccine"},{"key":"439_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/erv.11.32","volume":"10","author":"EL Su","year":"2011","unstructured":"Su EL, Snape MD. A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. Expert Rev Vaccines. 2011;10:575\u201388.","journal-title":"Expert Rev Vaccines"},{"key":"439_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2893.2009.01176.x","volume":"17","author":"Z Mor","year":"2010","unstructured":"Mor Z, Srur S, Dagan R, Rishpon S. Hepatitis A disease following the implementation of universal vaccination: who is at risk? J Viral Hepat. 2010;17:293\u20137.","journal-title":"J Viral Hepat"},{"key":"439_CR18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1017\/S0950268807009259","volume":"136","author":"C Stein-Zamir","year":"2008","unstructured":"Stein-Zamir C, Abramson N, Zentner G, Shoob H, Valinsky L, Block C. Invasive meningococcal disease in children in Jerusalem. Epidemiol Infect. 2008;136:782\u20139.","journal-title":"Epidemiol Infect"},{"key":"439_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S0950268800057472","volume":"112","author":"RJ Scholten","year":"1994","unstructured":"Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J. Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis. Epidemiol Infect. 1994;112:115\u201324.","journal-title":"Epidemiol Infect"},{"key":"439_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s150100050025","volume":"27","author":"G Paret","year":"1999","unstructured":"Paret G, Keller N, Barzilai A, et al. Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection. 1999;27:261\u20134.","journal-title":"Infection"},{"key":"439_CR21","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement. CLSI document M100-S15. Wayne, PA: NCCLS; 2005."},{"key":"439_CR22","first-page":"1","volume":"54","author":"OO Bilukha","year":"2005","unstructured":"Bilukha OO, Rosenstein N; National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54:1\u201321.","journal-title":"MMWR Recomm Rep"},{"key":"439_CR23","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1086\/315158","volume":"180","author":"NE Rosenstein","year":"1999","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992\u20131996. J Infect Dis. 1999;180:1894\u2013901.","journal-title":"J Infect Dis"},{"key":"439_CR24","doi-asserted-by":"publisher","first-page":"e979","DOI":"10.1542\/peds.2006-0281","volume":"118","author":"SL Kaplan","year":"2006","unstructured":"Kaplan SL, Schutze GE, Leake JA, et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 2006;118:e979\u201384.","journal-title":"Pediatrics"},{"key":"439_CR25","doi-asserted-by":"crossref","unstructured":"Delisle E, Larrieu S, Sim\u00f5es J, et al. Community outbreak of group B meningococcal disease in southwest France\u2014December 2008 to September 2009. Euro Surveill. 2010;15. pii: 19665. http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19665.","DOI":"10.2807\/ese.15.37.19665-en"},{"key":"439_CR26","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/01.inf.0000147642.85129.05","volume":"23","author":"AJ Pollard","year":"2004","unstructured":"Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004;23:S274\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"439_CR27","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/adc.2003.036004","volume":"89","author":"RS Heyderman","year":"2004","unstructured":"Heyderman RS, Ben-Shlomo Y, Brennan CA, Somerset M. The incidence and mortality for meningococcal disease associated with area deprivation: an ecological study of hospital episode statistics. Arch Dis Child. 2004;89:1064\u20138.","journal-title":"Arch Dis Child"},{"key":"439_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/S0950268800057733","volume":"112","author":"RE Stanwell-Smith","year":"1994","unstructured":"Stanwell-Smith RE, Stuart JM, Hughes AO, et al. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect. 1994;112:315\u201328.","journal-title":"Epidemiol Infect"},{"key":"439_CR29","first-page":"139","volume":"10","author":"JM Stuart","year":"1988","unstructured":"Stuart JM, Cartwright KA, Dawson JA, Rickard J, Noah ND. Risk factors for meningococcal disease: a case control study in south west England. Community Med. 1988;10:139\u201346.","journal-title":"Community Med"},{"key":"439_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/649209","volume":"50","author":"AC Cohn","year":"2010","unstructured":"Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50:184\u201391.","journal-title":"Clin Infect Dis"},{"key":"439_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1086\/517385","volume":"177","author":"DR Martin","year":"1998","unstructured":"Martin DR, Walker SJ, Baker MG, Lennon DR. New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J Infect Dis. 1998;177:497\u2013500.","journal-title":"J Infect Dis"},{"key":"439_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4161\/hv.6.2.10330","volume":"6","author":"J Stoddard","year":"2010","unstructured":"Stoddard J, Dougherty N. Universal immunization of infants against Neisseria meningitidis: addressing the remaining unmet medical need in the prevention of meningitis and septicemia. Hum Vaccin. 2010;6:219\u201333.","journal-title":"Hum Vaccin"},{"key":"439_CR33","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1086\/603552","volume":"49","author":"D Lennon","year":"2009","unstructured":"Lennon D, Jackson C, Wong S, Horsfall M, Stewart J, Reid S. Fast tracking the vaccine licensure process to control an epidemic of serogroup B meningococcal disease in New Zealand. Clin Infect Dis. 2009;49:597\u2013605.","journal-title":"Clin Infect Dis"},{"key":"439_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1586\/14760584.1.1.75","volume":"1","author":"D Bethell","year":"2002","unstructured":"Bethell D, Pollard AJ. Meningococcal vaccines. Expert Rev Vaccines. 2002;1:75\u201384.","journal-title":"Expert Rev Vaccines"},{"key":"439_CR35","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/S0264-410X(00)00528-4","volume":"19","author":"JC Bramley","year":"2001","unstructured":"Bramley JC, Hall T, Finn A, et al. Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4\u00a0months of age. Vaccine. 2001;19:2924\u201331.","journal-title":"Vaccine"},{"key":"439_CR36","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1001\/jama.2012.118","volume":"307","author":"AC Cohn","year":"2012","unstructured":"Cohn AC, Messonnier NE. Inching toward a serogroup B meningococcal vaccine for infants. JAMA. 2012;307:614\u20135.","journal-title":"JAMA"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-013-0439-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0439-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0439-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:14:44Z","timestamp":1744157684000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-013-0439-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["439"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0439-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,10]]},"assertion":[{"value":"26 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}